Jenny Brändstedt

Medicine & Life Sciences

1. alpha-2-HS-Glycoprotein 12%
2. Androgen Receptors 9%
3. Androgens 8%
4. Anti-Idiotypic Antibodies 7%
5. beta Catenin 25%
6. Breast Density 5%
7. Carcinogenesis 15%
8. Carcinoma 8%
9. Case-Control Studies 5%
10. Cell Cycle Proteins 10%
11. Chlamydia trachomatis 9%
12. Cisplatin 8%
13. Coenzyme A 10%
14. Cohort Studies 20%
15. Colorectal Neoplasms 61%
16. Cyclin D1 18%
17. Diet 10%
18. Genes 7%
19. Genetic Variation 8%
20. Glycoproteins 7%
21. Hip 7%
22. Histology 5%
23. Hormone Replacement Therapy 9%
24. Hormones 14%
25. Insulin-Like Growth Factor I 8%
26. Logistic Models 7%
27. Lymph Nodes 6%
28. Machine Learning 9%
29. Microsatellite Instability 25%
30. Mucins 5%
31. Mutation 6%
32. Neoplasm Metastasis 7%
33. Neoplasms 44%
34. Obesity 6%
35. Oral Contraceptives 12%
36. Ovarian Epithelial Carcinoma 100%
37. Ovarian Neoplasms 44%
38. Ovary 7%
39. Oxidoreductases 7%
40. Peritoneal Neoplasms 15%
41. Prospective Studies 9%
42. Recurrence 7%
43. RNA-Binding Motifs 13%
44. RNA-Binding Proteins 20%
45. Sex Factors 13%
46. Sexually Transmitted Diseases 8%
47. Survival 16%
48. Waist Circumference 7%
49. Waist-Hip Ratio 12%
50. Weights and Measures 5%